These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29916188)

  • 1. New horizons in breast cancer: the promise of immunotherapy.
    de la Cruz-Merino L; Palazón-Carrión N; Henao-Carrasco F; Nogales-Fernández E; Álamo-de la Gala M; Vallejo-Benítez A; Chiesa M; Sánchez-Margalet V;
    Clin Transl Oncol; 2019 Feb; 21(2):117-125. PubMed ID: 29916188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Immunology and Immunotherapy: Current Status and Future Perspectives.
    de la Cruz-Merino L; Chiesa M; Caballero R; Rojo F; Palazón N; Carrasco FH; Sánchez-Margalet V
    Int Rev Cell Mol Biol; 2017; 331():1-53. PubMed ID: 28325210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the role of immunotherapy in breast cancer?
    Tan TJ; Chan JJ; Kamis S; Dent RA
    Chin Clin Oncol; 2018 Apr; 7(2):13. PubMed ID: 29764158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.
    Gingras I; Azim HA; Ignatiadis M; Sotiriou C
    Clin Adv Hematol Oncol; 2015 Jun; 13(6):372-82. PubMed ID: 26352893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in Breast Cancer.
    Marmé F
    Oncol Res Treat; 2016; 39(6):335-45. PubMed ID: 27260697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for metastatic breast cancer.
    Sugie T
    Chin Clin Oncol; 2018 Jun; 7(3):28. PubMed ID: 30056730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
    Luen SJ; Savas P; Fox SB; Salgado R; Loi S
    Pathology; 2017 Feb; 49(2):141-155. PubMed ID: 28049579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for breast cancer: past, present, and future.
    Spellman A; Tang SC
    Cancer Metastasis Rev; 2016 Dec; 35(4):525-546. PubMed ID: 27913998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune approaches to the treatment of breast cancer, around the corner?
    Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G
    Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Immunotherapy in Metastatic Breast Cancer.
    Mansour M; Teo ZL; Luen SJ; Loi S
    Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer and immunology: biomarker and therapeutic developments.
    Santa-Maria CA; Park SJ; Jain S; Gradishar WJ
    Expert Rev Anticancer Ther; 2015; 15(10):1215-22. PubMed ID: 26358181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer genomics and immuno-oncological markers to guide immune therapies.
    Hammerl D; Smid M; Timmermans AM; Sleijfer S; Martens JWM; Debets R
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):178-188. PubMed ID: 29104025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Immunotherapy Strategies in Breast Cancer.
    Yu LY; Tang J; Zhang CM; Zeng WJ; Yan H; Li MP; Chen XP
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28085094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapeutics for breast cancer.
    Criscitiello C; Curigliano G
    Curr Opin Oncol; 2013 Nov; 25(6):602-8. PubMed ID: 24076578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1.
    Bertucci F; Gonçalves A
    Curr Oncol Rep; 2017 Aug; 19(10):64. PubMed ID: 28799073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoncology and tumor infiltrating lymphocytes-new strategies for therapy and diagnosis of breast cancer].
    Denkert C
    Pathologe; 2020 May; 41(3):248-253. PubMed ID: 32246201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.
    Ravelli A; Roviello G; Cretella D; Cavazzoni A; Biondi A; Cappelletti MR; Zanotti L; Ferrero G; Ungari M; Zanconati F; Bottini A; Alfieri R; Petronini PG; Generali D
    Tumour Biol; 2017 Apr; 39(4):1010428317695023. PubMed ID: 28378631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy strategies in the treatment of breast cancer.
    Soliman H
    Cancer Control; 2013 Jan; 20(1):17-21. PubMed ID: 23302903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.